Peptide care, in plain words
Bring the whole quote
Visit questions
You can bring the offer without bringing a yes. Ask the person in front of you to fill in the gaps.
Who is assessing me, and what profession are they in? Which state board holds their licence record?
The doctor’s state medical board grants licences and keeps public records of them, along with records of action against doctors for breaking professional rules.
The medical board for the state you are in during an online visit must give the doctor a licence or other legal permission, according to U.S. guidance checked September 26, 2026.
Find the state board through the directory in the chapter notes. In its record, match the person’s full name and licence number.
The U.S. agency called FDA is the Food and Drug Administration; its work includes reviewing medicines for approval.
Use the pharmacy link below, then choose your state on FDA’s page to search the state’s pharmacy licence records.
Telehealth describes a care visit held over video or phone, or through messages sent online.
An online prescription has to meet the patient’s state rules, which differ from state to state, as checked September 26, 2026.
Federal prescribing law did not impose blood tests on every prescription, as of September 26, 2026.
FDA can set extra testing rules for a particular medicine; state rules and your care needs also matter, as checked September 26, 2026.
The medical-board guidance calls for a doctor to arrange needed tests or send you to someone who can.
The Federation of State Medical Boards’ advice was checked September 17, 2026; it offers guidance for state boards, rather than national law.
Ask the prescriber whether the exact medicine needs a blood test, why, and who will arrange it.
Compounding means a pharmacist or doctor with a licence mixes or makes a medicine instead of supplying an approved ready-made product.
U.S. law allowed compounding only when its conditions were met, as of September 26, 2026.
For a regular pharmacy, those conditions include a prescription naming the patient, as of September 26, 2026.
A business could instead choose FDA registration as an outsourcing facility, meaning a place making batches of medicines, under the September 26, 2026 rules.
Under those rules, it need not be a pharmacy or obtain prescriptions naming each patient.
FDA oversees those registered businesses; state pharmacy boards are responsible for the everyday oversight of ordinary pharmacies.
The ingredient a pharmacy starts with must meet published quality rules for that ingredient, be in an approved medicine, or be on FDA’s allowed list, under rules checked September 26, 2026.
Ask who makes your medicine, which of these rules they follow, and which test its ingredient meets. Saying a medicine is compounded does not answer those questions.
Presenting a compounded product as FDA-approved was misleading, because these medicines had no such approval, as of September 26, 2026.
For compounded medicines, FDA did not check quality, benefit or safety before sale, as of September 26, 2026.
For medicines that require a prescription, U.S. federal rules still require a licensed prescriber’s order, as of September 26, 2026.
Put the answers beside the quote